Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Publisert: 04.08.2022

Navamedic ASA: Trading Update

Publisert: 04.07.2022

Navamedic ASA: Minutes of Annual General Meeting

Publisert: 02.06.2022

Navamedic ASA completes acquisition of Impolin AB and issues consideration shares

Publisert: 01.06.2022

Navamedic ASA: Q1 2022 financial results

Publisert: 10.05.2022

Navamedic ASA acquires Impolin AB and bolsters its product portfolio

Publisert: 05.05.2022